95 participants
An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2020-11-05
- Start Date:
- 2012-07-13
- Completion:
- 2019-09-27
Conditions
- Neoplasms
Interventions
- DRUG